CHRONIC HEPATITIS C(CHC)
Clinical trials for CHRONIC HEPATITIS C(CHC) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS C(CHC) trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS C(CHC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hepatitis c: triple therapy shows promise in late-stage trial
Disease control CompletedThis study tested a new drug called MP-424 combined with two standard medicines (interferon beta and ribavirin) in 74 adults with chronic hepatitis C (genotype 1 or 2). Participants either had never been treated before or had previously received interferon-based therapy. The main…
Matched conditions: CHRONIC HEPATITIS C(CHC)
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 18, 2026 11:50 UTC
-
New hope for hepatitis c: experimental drug combo shows promise in phase 3 trial
Disease control CompletedThis study tested a new drug called MP-424 combined with two standard hepatitis C medications (PEG-IFN Alfa-2a and RBV) in 54 adults with genotype 1 hepatitis C who either had never been treated or had relapsed after prior treatment. The main goal was to see if the virus was stil…
Matched conditions: CHRONIC HEPATITIS C(CHC)
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC